The role of atrial dilatation in development of chronic atrial fibrillation

Informazioni relative al progetto

NEUBERGER, HANS-RUPR

ID dell’accordo di sovvenzione: QLG1-CT-2000-51236

Progetto chiuso

Data di avvio 1 Gennaio 2001

Data di completamento 31 Dicembre 2002

Finanziato da

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Costo totale € 140 600,00

Contributo UE € 140 600,00

Coordinato da

UNIVERSITY OF MAASTRICHT
Netherlands

Obiettivo

The project investigates whether chronic a trial dilatation plays a causal role in a trial fibrillation. It uses a new method in a well-established goat model and will help to develop effective therapeutic strategies against this important arrhythmia.

Campo scientifico

Not validated

• medical and health sciences › clinical medicine › cardiology › cardiovascular diseases › cardiac arrhythmia

Programma(i)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Argomento(i)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

RGI - Research grants (individual fellowships)

Coordinatore

UNIVERSITY OF MAASTRICHT

• Contributo UE: Nessun dato
• Indirizzo: Universiteitssingel 50 ; 6200 MB MAASTRICHT ; Paesi Bassi
• Costo totale: Nessun dato